Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 523 of 710

Advanced search

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06817460: A Clinical Study Comparing the Effectiveness and Safety of Two Surgical Pathways for Laparoscopic Total Hysterectomy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06781931: [Trial of device that is not approved or cleared by the U.S. FDA]

Study type: . Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06780046: Study That Will Evaluate the Brazilian Population With COPD.

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06764316: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06662058: Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06587295: Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06465368: A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06264180: VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06084208: Assessment of Diagnostic Yield Using a Robotic Navigational Bronchoscopy System With CBCT

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT06042725: MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05853367: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05800015: A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05594043: A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05342597: Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05260268: Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT05039632: Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT04837040: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT04029090: A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT03891446: Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT03172689: Validation of CardioQ Versus PiCCO in Children

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT02760849: Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT02276443: Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT01371630: Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 15Researchclinicaltrials.govTier 1 · Trial registry

NCT00501826: Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Erasca (ERAS) Surges 8.9% on Encouraging Cancer Trial Results

Yahoo Finance SingaporeOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

PR NewswireOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Dothan Named Hub for $15M Biotech Project

Wiregrass Daily NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ASU, Callan JMB Partner to Boost Alabama’s Workforce and Pharmaceutical Industry

Alabama State UniversityOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Lessons Learned on Commercializing an Allogeneic T Cell Therapy

Fierce BiotechOriginal source

🇺🇸Jul 15Devicesorthopediatrics.comTier 1 · Company source

Pediatric Plating Platform™ | Hip (Deformity)

OrthoPediatricsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Oric Pharmaceuticals (ORIC) Launches Phase 3 Trial for Prostate Cancer Treatment

GuruFocusOriginal source

🇺🇸Jul 15Industrybiomarin.comTier 1 · Company source

Becky Jackson Curran Advocates for Accessibility and Understanding

BioMarin PharmaceuticalOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?

The Motley FoolOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ORIC Pharmaceuticals initiates phase 3 prostate cancer trial

Investing.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss

sharewise.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer

The Manila TimesOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ORIC Pharmaceuticals initiates phase 3 prostate cancer trial By Investing.com

Investing.com IndiaOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Alzheimer’s Tau Drug Slows Cognitive Decline and Cuts Brain Tangles in Trial

Tech TimesOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Petition asks FDA to implement new OEM rule for MRI safety

AuntMinnieOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Biogen plans phase 3 trial for Alzheimer’s drug diranersen

Investing.com UKOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Bayer Will Provide NUBEQA at No Cost for ORIC’s Global Trial

Stock TitanOriginal source

🌍Jul 15Industryinvestors.vivani.comTier 1 · Company source

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

Vivani MedicalOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

OpenAI’s $1 Trillion IPO Bet Faces Apple Lawsuit, Market Doubt, and Rival’s Profit

Tech TimesOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Potential first-in-class treatment for SCD awarded FDA priority review

Sickle Cell Disease NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Bar-Ilan University and Sheba Medical Center Joining Forces for Biotech Innovation Institute With $120 Million Investment

Jewish JournalOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

What’s the status of House lawmakers’ bill on China biotech restrictions?

Endpoints NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Momentum will continue in the biotech sector, says Mizuho's Jared Holz

CNBCOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors

Oncology Nursing NewsOriginal source

🇺🇸Jul 15CROmedidata.comTier 2 · Direct publisher

Friends of Cancer Research’s Jeff Allen on External Control Arms and Cancer Trials

Medidata SolutionsOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Post-Hoc Live: What’s making biotech IPOs work again?

Endpoints NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

The Blueprint for a Bigger Medical Bureaucracy: News Article

Independent InstituteOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA Finalizes Psychedelic Trial Rules: Unblinding Problem Gets Official Answer

Tech TimesOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA Approves Subcutaneous Formulation of Leqembi Iqlik | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Penny for Your Thoughts: Episode 14

Pharmaceutical CommerceOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Biogen defends anti-tau drug after stock slides on Alzheimer’s readout

Fierce BiotechOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN Trial in MSS Colon Cancer

OncodailyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Spero Therapeutics: 'Buy' Utebzi Royalty Deal For Funding And SP001 In-Licensing (SPRO)

Seeking AlphaOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA suspends licences of three Mumbai hotels over serious food safety violations

ANI NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

4 Best CRISPR Companies to Buy in 2026 and How to Invest

The Motley FoolOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Q&A: What Will It Take to Reshore US Drug Manufacturing?

Pharmaceutical CommerceOriginal source